Drug Manufacturers - Specialty & Generic · Healthcare
Board Member, CEO
2025-12-01–2026-03-20
Equibles does not estimate personal net worth.
Earlier roles on record: CEO at Apimeds Pharmaceuticals US, Inc. (APUS) until March 20, 2026 and Board Member at Apimeds Pharmaceuticals US, Inc. (APUS) until December 5, 2025. Apimeds Pharmaceuticals US, Inc. reported in an 8-K filed March 25, 2026 that Dr. Vin Menon was terminated as Chief Executive Officer, effective March 20, 2026. Apimeds Pharmaceuticals US, Inc. reported in an 8-K filed December 10, 2025 that Dr. Vin Menon resigned as Director, effective December 5, 2025.
“the newly-constituted Board removed Dr. Vin Menon as Chief Executive Officer of the Company and from all other positions held at the Company and its subsidiaries, effective immediately”
“On December 5, 2025, Dr. Vin Menon, a Director of Apimeds Pharmaceuticals US, Inc. (the "Company"), and Amir A. Dossal, an Independent Director of the Company, resigned from their positions on the Company's Board of Directors.”
2025-12-01–2025-12-05
2025-12-01–2026-03-20
Drug Manufacturers - Specialty & Generic · Healthcare
Board Member, CEO
2025-12-01–2026-03-20